Profiel
Daniel Kaplan is currently the Chief Scientific Officer at NGM Biopharmaceuticals, Inc. He started this position in 2023.
Prior to his current role, he obtained a doctorate degree from Duke University and an undergraduate degree from the University of California San Diego.
Actieve functies van Daniel Kaplan
| Bedrijven | Functie | Begin |
|---|---|---|
| NGM BIOPHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-04-2023 |
Opleiding van Daniel Kaplan
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
NGM Biopharmaceuticals, Inc.
NGM Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel & life-changing medicines | Health Technology |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California San Diego
University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















